Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.79−0.14 (-7.25%)
Close on Nov 12, 2026Market cap $2.92MP/E –Yield –
Ernexa Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ernexa Therapeutics's price to book ratio was 0.7× on Nov 11, 2026, against 74.2× a year earlier. Over the last 5 years it ranged from 0.5× to 457.3×, with a median of 188.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −65.3 |
| 2025 | Dec 31, 2025 | 66.0× | −391.4 |
| 2023 | Apr 28, 2023 | 457.3× | +54.3 |
| 2022 | Dec 30, 2022 | 403.1× | +292.2 |
| 2019 | Oct 31, 2019 | 110.9× | −99.6 |
| 2018 | Jan 31, 2018 | 210.4× | +53.1 |
| 2017 | Dec 29, 2017 | 157.4× | −280.1 |
| 2013 | Oct 31, 2013 | 437.4× | +252.7 |
| 2012 | Dec 31, 2012 | 184.7× | −3.7 |
| 2011 | Dec 30, 2011 | 188.4× | – |
See a number that looks wrong?